96 related articles for article (PubMed ID: 10049057)
1. RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML).
Flotho C; Valcamonica S; Mach-Pascual S; Schmahl G; Corral L; Ritterbach J; Hasle H; Aricò M; Biondi A; Niemeyer CM
Leukemia; 1999 Jan; 13(1):32-7. PubMed ID: 10049057
[TBL] [Abstract][Full Text] [Related]
2. LNK/
Wintering A; Hecht A; Meyer J; Wong EB; Hübner J; Abelson S; Feldman K; Kennedy VE; Peretz CAC; French DL; Maguire JA; Jobaliya C; Vasquez MR; Desai S; Dulman R; Nemecek E; Haines H; Hammad M; El Haddad A; Kogan SC; Abdullaev Z; Chehab FF; Tasian SK; Smith CC; Loh ML; Stieglitz E
Haematologica; 2023 Dec; ():. PubMed ID: 38152053
[TBL] [Abstract][Full Text] [Related]
3. KRAS mutations, autoimmunity and female sex in chronic myelomonocytic leukemia.
Osman AEG; Rets A; Patel AB
Leuk Res; 2024 Mar; 138():107466. PubMed ID: 38430640
[No Abstract] [Full Text] [Related]
4. Ras-associated autoimmune lymphoproliferative disorder.
Sullivan KE; Lambert M
Br J Haematol; 2024 May; ():. PubMed ID: 38797558
[TBL] [Abstract][Full Text] [Related]
5. Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia.
Sakaguchi H; Okuno Y; Muramatsu H; Yoshida K; Shiraishi Y; Takahashi M; Kon A; Sanada M; Chiba K; Tanaka H; Makishima H; Wang X; Xu Y; Doisaki S; Hama A; Nakanishi K; Takahashi Y; Yoshida N; Maciejewski JP; Miyano S; Ogawa S; Kojima S
Nat Genet; 2013 Aug; 45(8):937-41. PubMed ID: 23832011
[TBL] [Abstract][Full Text] [Related]
6. Bedside to bench in juvenile myelomonocytic leukemia: insights into leukemogenesis from a rare pediatric leukemia.
Chang TY; Dvorak CC; Loh ML
Blood; 2014 Oct; 124(16):2487-97. PubMed ID: 25163700
[TBL] [Abstract][Full Text] [Related]
7. Clinical course of juvenile myelomonocytic leukemia in the blast crisis phase treated by acute myeloid leukemia-oriented chemotherapy and allogeneic hematopoietic stem cell transplantation.
Ueda S; Sakata N; Muramatsu H; Sakaguchi H; Wang X; Xu Y; Kojima S; Yamaguchi T; Higa T; Takemura T
Int J Hematol; 2014 Nov; 100(5):502-6. PubMed ID: 25047104
[TBL] [Abstract][Full Text] [Related]
8. Juvenile myelomonocytic leukemia: a report from the 2nd International JMML Symposium.
Chan RJ; Cooper T; Kratz CP; Weiss B; Loh ML
Leuk Res; 2009 Mar; 33(3):355-62. PubMed ID: 18954903
[TBL] [Abstract][Full Text] [Related]
9. Integrated molecular profiling of juvenile myelomonocytic leukemia.
Murakami N; Okuno Y; Yoshida K; Shiraishi Y; Nagae G; Suzuki K; Narita A; Sakaguchi H; Kawashima N; Wang X; Xu Y; Chiba K; Tanaka H; Hama A; Sanada M; Ito M; Hirayama M; Watanabe A; Ueno T; Kojima S; Aburatani H; Mano H; Miyano S; Ogawa S; Takahashi Y; Muramatsu H
Blood; 2018 Apr; 131(14):1576-1586. PubMed ID: 29437595
[TBL] [Abstract][Full Text] [Related]
10. [Ras-associated autoimmune leukoproliferative disorder: a report of 2 cases and literature review].
He TY; Li CR; Xia Y; Liang FF; Luo Y; Yang J
Zhonghua Er Ke Za Zhi; 2017 Nov; 55(11):853-857. PubMed ID: 29141318
[No Abstract] [Full Text] [Related]
11. Blastic transformation of juvenile myelomonocytic leukemia caused by the copy number gain of oncogenic KRAS.
Osumi T; Kato M; Ouchi-Uchiyama M; Tomizawa D; Kataoka K; Fujii Y; Seki M; Takita J; Ogawa S; Uchiyama T; Ohki K; Kiyokawa N
Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28244637
[TBL] [Abstract][Full Text] [Related]
12. JMML and RALD (Ras-associated autoimmune leukoproliferative disorder): common genetic etiology yet clinically distinct entities.
Calvo KR; Price S; Braylan RC; Oliveira JB; Lenardo M; Fleisher TA; Rao VK
Blood; 2015 Apr; 125(18):2753-8. PubMed ID: 25691160
[TBL] [Abstract][Full Text] [Related]
13. Determination of Ras-GTP and Ras-GDP in patients with acute myelogenous leukemia (AML), myeloproliferative syndrome (MPS), juvenile myelomonocytic leukemia (JMML), acute lymphocytic leukemia (ALL), and malignant lymphoma: assessment of mutational and indirect activation.
Raepple D; von Lintig F; Zemojtel T; Duchniewicz M; Jung A; Lübbert M; Boss GR; Scheele JS
Ann Hematol; 2009 Apr; 88(4):319-24. PubMed ID: 18784923
[TBL] [Abstract][Full Text] [Related]
14. Phase Separation as a Driver of Stem Cell Organization and Function during Development.
Parra AS; Johnston CA
J Dev Biol; 2023 Dec; 11(4):. PubMed ID: 38132713
[TBL] [Abstract][Full Text] [Related]
15. Genomic and Epigenomic Landscape of Juvenile Myelomonocytic Leukemia.
Fiñana C; Gómez-Molina N; Alonso-Moreno S; Belver L
Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267643
[TBL] [Abstract][Full Text] [Related]
16. Current Treatment of Juvenile Myelomonocytic Leukemia.
Mayerhofer C; Niemeyer CM; Flotho C
J Clin Med; 2021 Jul; 10(14):. PubMed ID: 34300250
[TBL] [Abstract][Full Text] [Related]
17. Physiological and Aberrant γ-Globin Transcription During Development.
Barbarani G; Labedz A; Stucchi S; Abbiati A; Ronchi AE
Front Cell Dev Biol; 2021; 9():640060. PubMed ID: 33869190
[TBL] [Abstract][Full Text] [Related]
18. Juvenile myelomonocytic leukemia-A comprehensive review and recent advances in management.
Gupta AK; Meena JP; Chopra A; Tanwar P; Seth R
Am J Blood Res; 2021; 11(1):1-21. PubMed ID: 33796386
[TBL] [Abstract][Full Text] [Related]
19. Pediatric Neoplasms Presenting with Monocytosis.
Greenmyer JR; Kohorst M
Curr Hematol Malig Rep; 2021 Jun; 16(3):235-246. PubMed ID: 33630234
[TBL] [Abstract][Full Text] [Related]
20. The Emerging Role of Ras Pathway Signaling in Pediatric Cancer.
Ney GM; McKay L; Koschmann C; Mody R; Li Q
Cancer Res; 2020 Dec; 80(23):5155-5163. PubMed ID: 32907837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
